Literature DB >> 28429360

Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line.

X-M Ding1, J-X Li, K Wang, Z-S Wu, A-H Yao, C-Y Jiao, J-J Qian, D-S Bai, X-C Li.   

Abstract

OBJECTIVE: We investigated the expression of annexin A5 (ANXA5) in human cholangiocarcinoma (CCA) cell line and its effect on proliferation, migration, and apoptosis of human CCA cells.
MATERIALS AND METHODS: Expression of ANXA5 was detected by fluorescent quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and western blotting method in 2 human CCA cell lines, QBC939 and RBE. 3 shRNA plasmids for ANXA5 silencing (ANXA5-sh1, ANXA5-sh2, ANXA5-sh3) and 1 negative control plasmid were constructed to infect QBC939 cells. The infection efficiency, expression of ANXA5, apoptosis and cell cycle of QBC939 cell were measured separately.
RESULTS: The expression of ANXA5 in QBC939 cell was significantly higher than RBE cell. Expressed ANXA5 protein in the QBC939-KD cell (QBC939 cell treated by RNAi) was significantly lower than QBC939-BC (QBC939 cell) and QBC939-NC cells (QBC939 cell treated by scramble plasmid). The ratio of G0/1 phase cells and apoptosis rate increased in QBC939-KD cell. The proliferation activity and invasion ability decreased in QBC939-KD cell compared with QBC939-NC and QBC939-BC cells.
CONCLUSIONS: ANXA5 play important role in the migration and apoptosis of CCA cells. Inhibiting the expression of ANXA5 significantly reduce the proliferation, migration and invasion ability of QBC939 cells, and increase the apoptosis of QBC939 cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28429360

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Annexin A5 suppression promotes the progression of cervical cancer.

Authors:  Xiaojie Wang; Yarui Dai; Jialu Zhang; Xin Li
Journal:  Arch Gynecol Obstet       Date:  2022-07-07       Impact factor: 2.344

2.  AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells via ERK Pathway.

Authors:  Xiaojie Wang; Yarui Dai; Yina Zhao; Meichuan Li; Jialu Zhang; Yunzhe Ci; Huan Wang; Xin Li
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

3.  Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.

Authors:  Xujuan Sun; Shuqing Liu; Jinxia Wang; Bin Wei; Chunmei Guo; Chen Chen; Ming-Zhong Sun
Journal:  Cell Death Dis       Date:  2018-05-25       Impact factor: 8.469

4.  Defective membrane repair machinery impairs survival of invasive cancer cells.

Authors:  F Bouvet; M Ros; E Bonedeau; C Croissant; L Frelin; F Saltel; V Moreau; A Bouter
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

5.  Molecular analysis of Annexin expression in cancer.

Authors:  Tobias Hein; Peter H Krammer; Heiko Weyd
Journal:  BMC Cancer       Date:  2022-09-19       Impact factor: 4.638

Review 6.  Pathobiological functions and clinical implications of annexin dysregulation in human cancers.

Authors:  Llara Prieto-Fernández; Sofía T Menéndez; María Otero-Rosales; Irene Montoro-Jiménez; Francisco Hermida-Prado; Juana M García-Pedrero; Saúl Álvarez-Teijeiro
Journal:  Front Cell Dev Biol       Date:  2022-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.